Alustal European Dust Mite Extract Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

alustal european dust mite extract

stallergenes greer new zealand ltd - allergen extracts 10 ir/ml (dermatophagoides pteronyssinus body extract) - solution for injection - 10 ir/ml - active: allergen extracts 10 ir/ml (dermatophagoides pteronyssinus body extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Alustal Extract of Five Grasses Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

alustal extract of five grasses

stallergenes greer new zealand ltd - allergen extracts 10 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) - solution for injection - 10 ir/ml - active: allergen extracts 10 ir/ml (d. glomerate (20%), f. elatior (20%), l. perenne (20%), a. odoratum (20%), p. pratense (20%) extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water - alustal treatment is indicated for patients with type 1 allergy (gell and coombs classification), particularly presenting as seasonal or perennial rhinitis, conjunctivitis, rhinoconjunctivitis with or without associated asthma.

Alustal Fat Hen Pollen Extract Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

alustal fat hen pollen extract

stallergenes greer new zealand ltd - allergen extracts 10 ic/ml (chenopodium album pollen extract) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (chenopodium album pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Alustal Oleaceae Pollen Mix Extract Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

alustal oleaceae pollen mix extract

stallergenes greer new zealand ltd - allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (fraxinus excelsior (33.33%), olea europaea (33.33%), ligustrum vulgare (33.33%) pollen extracts) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Alustal Plantain Pollen Extract Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

alustal plantain pollen extract

stallergenes greer new zealand ltd - allergen extracts 10 ic/ml (plantago lanceolata pollen extract) - solution for injection - 10 ic/ml - active: allergen extracts 10 ic/ml (plantago lanceolata pollen extract) excipient: aluminium hydroxide gel mannitol phenol sodium chloride water

Arrow - Quinapril 10 Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

arrow - quinapril 10

teva pharma (new zealand) limited - quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril;  ; quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril - film coated tablet - 10 mg - active: quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril   excipient: crospovidone heavy magnesium carbonate hyprolose isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide active: quinapril hydrochloride 10.85mg equivalent to 10 mg quinapril excipient: crospovidone heavy magnesium carbonate hyprolose isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide - quinapril is indicated for the treatment of essential hypertension. quinapril is effective as monotherapy or concomitantly with diuretics and beta-blockers in patients with hypertension. quinapril is effective in the treatment of congestive heart failure when given concomitantly with a diuretic and/or digoxin.

Benzac AC Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

benzac ac

pharmacy retailing (nz) ltd t/a healthcare logistics - benzoyl peroxide 10%{relative};   - topical gel - 10% w/w - active: benzoyl peroxide 10%{relative}   excipient: acrylates copolymer carbomer 940 colloidal silicon dioxide disodium edetate dihydrate docusate sodium glycerol poloxamer propylene glycol sodium hydroxide water - latest regulatory activity

Colifoam Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

colifoam

viatris limited - hydrocortisone acetate 10.5%{relative} (includes 5 % excess) - foam - 10% w/w - active: hydrocortisone acetate 10.5%{relative} (includes 5 % excess) excipient: cetyl alcohol emulsifying wax methyl hydroxybenzoate polyoxyethylene stearyl ether propyl hydroxybenzoate propylene glycol purified water trolamine - colifoam rectal foam is indicated for topical treatment of inflammation occurring in the rectal mucosa, e.g. ulcerative colitis, proctosigmoiditis and granular proctitis.

Creon 10,000 Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

creon 10,000

viatris limited - pancreatin 150mg (amylase 8,000 ph eur u, lipase 10,000 ph eur u, total protease 600 ph eur u.); pancreatin 150mg equivalent to amylase 8,000 ph eur u, lipase 10,000 ph eur u, total protease 600 ph eur u. - modified release capsule - 150 mg - active: pancreatin 150mg (amylase 8,000 ph eur u, lipase 10,000 ph eur u, total protease 600 ph eur u.) excipient: acetone dibutyl phthalate dimeticone gelatin hypromellose phthalate iron oxide black iron oxide red iron oxide yellow liquid paraffin macrogol 4000 propyl alcohol titanium dioxide active: pancreatin 150mg equivalent to amylase 8,000 ph eur u, lipase 10,000 ph eur u, total protease 600 ph eur u. excipient: cetyl alcohol dimeticone ferrosoferric oxide gelatin hypromellose phthalate iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate titanium dioxide triethyl citrate - creon is indicated for the treatment of pancreatic exocrine insufficiency (pei) in paediatric and adult patients. pancreatic exocrine insufficiency is often associated with, but not limited to: · cystic fibrosis · chronic pancreatitis · post-pancreatectomy · post-gastrointestinal bypass surgery ,(e.g. billroth ii, gastroenterostomy) · ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).

Fluorescite Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

fluorescite

alcon laboratories (new zealand) limited - fluorescein 10%{relative} (converted to sodium fluorescein in situ) - solution for injection - 10 % - active: fluorescein 10%{relative} (converted to sodium fluorescein in situ) excipient: hydrochloric acid as 1n solution, to ph 9.0-9.8 sodium hydroxide as 1n solution, to ph 9.0-9.8 water for injection - diagnostic fluorescein angiography or angioscopy of the fundus and of the iris vasculature.